2 Days to Go: Qiming Venture Partners' 2025 WAIC Entrepreneurship and Investment Forum — Venture Capital Enters a Resonance Cycle of AI Technology and Applications
This sub-forum will showcase and explore the latest breakthroughs in AI technology and applications through an innovation lens. Qiming Venture Partners will bring together leading scholars and pioneering entrepreneurs in the field — from both the startup and investment perspectives — for four keynote speeches and four panel discussions.
2 Days Until the WAIC World Artificial Intelligence Conference
Qiming Venture Partners · Entrepreneurship and Investment Forum
Venture Capital Enters a Resonance Cycle of AI Technology and Applications
The Countdown Begins!
This is a sub-forum
showcasing and exploring the latest breakthroughs in AI technology and applications
through the lens of innovation
From the perspectives of entrepreneurship and investment,
we join hands with leading scholars and pioneering founders in the field
to bring you
4 Keynote Speeches
4 Panel Discussions
Where is the next stop in the evolution of large model technology?
Are world models the critical path to AGI?
When will Embodied Artificial Intelligence achieve large-scale commercial deployment?
Is AI hardware a blue ocean market for Chinese entrepreneurs?
Can startups escape the "shadow of the giants"?
Which fields hold the next wave of disruptive entrepreneurial opportunities?
Monday, July 28, 9:00 AM
Registered attendees are welcome
to join us at
Blue Hall, 4th Floor, Shanghai World Expo Center
(Gate 2, No. 1500 Expo Avenue, Pudong New Area, Shanghai, China)
Please present your successful reservation e-ticket for pre-check at entry
Pass through the turnstile via facial recognition
(Please bring your original ID card for verification)
Full Forum Agenda
Also, we invite everyone to visit the Qiming Venture Partners exhibition booth at the WAIC World Artificial Intelligence Conference — Booth L002, M Floor, Shanghai World Expo Center (Gate 2, No. 1500 Expo Avenue, Pudong New Area, Shanghai, China) — to discover more exciting content
PAST HIGHLIGHTS
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early- and growth-stage companies in Technology and Healthcare.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 companies have become recognized unicorns or super-unicorns in their industries.
Many companies in Qiming Venture Partners' portfolio have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Insta360 (688775.SH), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), Genrix Bio (688520.SH), Yuanxin Technology, Insilico Medicine, MediLink Therapeutics, LaNova Medicines, Zhipu AI, StepFun, Biren Technology, and others.